XBiotech (XBIT) Stock: Buy, Sell, or Hold?
$1.98
+0.01 (+0.51%)
â˛
5d:
+1.54%
30d:
-8.33%
90d:
-15.02%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
53/100
Position
FAIR
30-Day Fair Range
$1.90 â $2.16
Position: FAIR
Wall Street Target
$18.00
+813.7% upside
Options IV & Volume
41th pct IV
HIGH volume confirmation
Support / Resistance
$1.85 / $2.13
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: XBIT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $1.98, which is considered fair relative to its 30-day fair value range of $1.90 to $2.16.
Technical Outlook: Technically, XBIT is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $2.13.
Market Sentiment: XBIT scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+813.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, XBIT is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $2.13.
Market Sentiment: XBIT scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+813.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.90 -
$2.16
Company Quality Score
53/100
(HOLD)
Options IV Signal
41th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
83.3%
Trading Range & Key Levels
30-Day Trading Range
$1.90 -
$2.16
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$0.32
(16.1%)
Support Level
$1.85
Resistance Level
$2.13
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 41th percentile)
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 813.7% below Wall St target ($18.00)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Wall Street Target
$18.00
(+813.7%)
Revenue Growth (YoY)
-93.3%
Share XBIT Analysis
Share this live XBIT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (XBIT)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish sentiment was observed on StockTwits regarding $XBIT with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:39 PM ET
Data refreshes hourly during market hours. Next update: 3:39 PM
Data refreshes hourly during market hours. Next update: 3:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive XBIT Research Pages
